Natural Cycle & Mild stimulation IVF/ICSI in women with Poor Ovarian Response (POR)

Similar documents
Modified natural cycles: the Italian experience

LOW RESPONDERS. Poor Ovarian Response, Por

Individualized treatment based on ovarian reserve markers

Treatment of Poor Responders

Principles of Ovarian Stimulation

Influence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser

Fertility assessment and assisted conception

How to make the best use of the natural cycle for frozen-thawed embryo transfer?

Poor & Hyper responders: what is the best approach?

How to make the best use of the natural cycle for frozen-thawed embryo transfer?

New York Science Journal 2014;7(4)

A Tale of Three Hormones: hcg, Progesterone and AMH

L6: DuoStim: the alternative of oocytes/embryos accumulation programs Carlo Alviggi

Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used

Female Reproductive System. Lesson 10

L2. Optimising IVF outcomes through increased number of oocytes... 03

The old IVF patient: An evidence based approach. Stratis Kolibianakis MD MSc PhD

Infertility Clinical Guideline

Minimising IVF related mortality and morbidity. Scott Nelson Muirhead Professor in Obstetrics & Gynaecology

Dr Guy Gudex. Director Repromed. 17:00-17:30 Recent Advances in Fertility Management

% Oocyte Donation Pregnancyes (days 3)

Puberty and Fertility. Normal Female Puberty PUBERTY! What about girls with Galactosemia? E Puberty and Fertility Badik Spencer 1

Progesterone and clinical outcomes

Is it the seed or the soil? Arthur Leader, MD, FRCSC

INDICATIONS OF IVF/ICSI

Ivf day 6 estradiol level

Modified natural cycle IVF and mild IVF: a 10 year Swedish experience

Manish Banker. Declared receipt of grants; member of a company advisory board, board of director or similar group

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF

A multi-centre, multinational, cross-sectional, incident case control study on Factors associated with the development of

Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization

Infertility treatment

STIMULATION AND OVULATION TRIGGERING

Honorary Fellow of the Royal College of Obs. & Gyn. First Indian to receive FIGO s Distinguished Merit Award for Services towards women s health.

Ovarian hyperstimulation syndrome (OHSS)

Clinical Study The Prognosis of IVF in Poor Responders Depending on the Bologna Criteria: A Large Sample Retrospective Study from China

(BMI)=18.0~24.9 kg/m 2 ;

Sample size a Main finding b Main limitations

LUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi

Best practices of ASRM and ESHRE

A prospective randomised study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF

Advanced age, poor responders and the role of LH supplementation. C. Alviggi University Federico II, Naples, Italy

Intérêt de l hcg et induction de l ovulation. Christophe Blockeel, MD, PhD Centre for Reproductive Medicine, Brussels, Belgium

Are all-freeze cycles & frozen-thawed embryo transfers improving IVF outcomes?

Thrombosis during assisted reproduction. Scott Nelson Muirhead Chair in Obstetrics & Gynaecology

Premature progesterone elevation impairs implantation and live birth rates in GnRH-agonist IVF/ICSI cycles

LH activity administration during the

lbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour

Price List. Valid from 1 st April 2017

2013 Sep.; 24(3):

Use of in vitro maturation for fertility preservation

Biomarkers for Prediction of Pregnancy Outcome in Fertility Patients. Scott Nelson Muirhead Chair in Obstetrics & Gynaecology

IN VITRO FERTILISATION (IVF)

NICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic


1 (gonadotropin, Gn) -,, : - (IVF-ET); (COH); ; : R711.6 : A : X(2014)

Natural-cycle in vitro fertilization in poor responder patients: a survey of 500 consecutive cycles

Biology of fertility control. Higher Human Biology

A comparative study between agonist and antagonist protocol for ovarian stimulation in art cycles at a rural set up in South Gujarat

Patient Price List. t: e: w:

Prognostic factors of ovarian response and IVF outcome in patients with deep infiltrating endometriosis Claire GAUCHE-CAZALIS, Chadi YAZBECK

Ovarian response in three consecutive in vitro fertilization cycles

Scientific Highlights: First world conference on luteinizing hormone in ART: Landing in Asia Pacific

IVM in PCOS patients. Introduction (1) Introduction (2) Michael Grynberg René Frydman

Minimal stimulation using recombinant follicle-stimulating hormone and a gonadotropin-releasing hormone antagonist in women of advanced age

COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL

NATURAL NATU CYCLES RAL

Clinical consequences of ovarian stimulation in assisted conception and in PCOS Al-Inany, H.G.

IVF Protocols: Hyper & Hypo-Responders, Implantation

Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M

(1.,, ) (2.,,, )

IVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)

2013 Sep.; 24(3):

Dipartimento di Neuroscienze, Scienze Riproduttive ed Odontostomatologiche. Tecniche di sincronizzazione ovocitaria. La sincronizzazione follicolare

Assisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi

Luteal phase rescue after GnRHa triggering Progesterone and Estradiol

Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? *

ENDOCRINE CHARACTERISTICS OF ART CYCLES

Prognosticating ovarian reserve by the new ovarian response prediction index

Serum progesterone levels on the day of hcg trigger and ICSI outcome: a retrospective observational cohort study

Hana Park, Chung-Hoon Kim, Eun-Young Kim, Jei-Won Moon, Sung-Hoon Kim, Hee-Dong Chae, Byung-Moon Kang

Effect of ovarian stimulation on oocyte quality and embryonic aneuploidy: a prospective, randomised controlled trial

Dr. Ernesto Bosch Instituto Valenciano de Infertilidad Valencia, Spain. Declared no potential conflict of interest

10.7 The Reproductive Hormones

Summary

Clinical Study Comparison of IVF Outcomes between Minimal Stimulation and High-Dose Stimulation for Patients with Poor Ovarian Reserve

Fertility Policy. December Introduction

Article Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment

What is the POSEIDON concept?

IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW

Anti-Mullerian hormone (AMH) as predictor of ovarian reserve

Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists

In Vitro Fertilization in Clomiphene-Resistant Women with Polycystic Ovary Syndrome

Vanessa N. Weitzman, M.D., Lawrence Engmann, M.D., Andrea DiLuigi, M.D., Donald Maier, M.D., John Nulsen, M.D., and Claudio Benadiva, M.D.

A Tale of Three Hormones: hcg, Progesterone and AMH

Optimizing the Management of the Poor Responder. Kaylen Silverberg, M.D. Texas Fertility Center Austin, Texas

Infertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF

I. ART PROCEDURES. A. In Vitro Fertilization (IVF)

Short-term, low-dose, non-steroidal anti-inflammatory drug application diminishes premature ovulation in natural-cycle IVF I

Transcription:

Natural Cycle & Mild stimulation IVF/ICSI in women with Poor Ovarian Response (POR) Geeta Nargund Head of Reproductive Medicine St George s Hospital London

ISMAAR Terminology Human Reprod Nargund et al 2007 Terminology Aim Methodology Natural cycle IVF Single oocyte No medication Modified Natural cycle IVF Single oocyte hcg only Antagonist & FSH/HMG addback Mild IVF 2-7 oocytes Low dose FSH/HMG, oral compounds & antagonist Conventional IVF 8 oocytes Agonist or antagonist conventional FSH/HMG dose

Modified Natural cycle IVF Spontaneous cycle Exogenous hormones used Scenarios: 1. hcg only 2. GnRH antagonist ±FSH add-back & hcg 3. Indomethacin 4. Luteal support Low risk of cancellation Commonly used method of natural cycle IVF Rongieres-Bertrand et al:hum Reprod,1999;14:683 688 Nargund & Frydman: RBM Online,2007;14;550-552

Natural /Modified natural cycle IVF Cohort studies Cumulative data Mainly retrospective In selected population 1. Poor responders 2. Failed implantation 3. Older women

Modified Natural Cycle IVF Feldman B et al: Gynae Endo 2001 Nargund et al: Human Reprod 2001 Ubaldi FM : RBM online 2005 -Favourable in poor responders & failed implantation -The use of antagonists did not change intrafollicular VEGF/Inhibin A levels -Endometrium favourable for implantation

Semi-Natural Cycle IVF For Poor responders/low ovarian reserve/failed implantation 1. Castlo-Branco,Frydman et al 2004 133 cycles/16.6% pregnancy/oocyte collection 2. Elizur S 2005-540 cycles-agonist/antagonist/natural IVF 10.6%/6.75%/10.2% pregnancy/cycle Semi-Natural Cycle is a feasible alternative

Natural/Modified Natural IVF-Protocol Counselling,options & informed decision Pre-IVF scan Assessment of cycle length & ovulation Two monitoring scans E2 & LH if required 150 IU FSH & Antagonist from follicle 14mm Indomethacin if appropriate Egg collection at 16mm+ Embryo Transfer Day 2-3 Luteal support Progesterone

Medication used to prevent LH surge/ ovulation in modified natural cycles Indomethacin (50mg TDS) Antagonist (2-3 days) Indomethacin + Antagonist

Indications for King s study Primary infertility & previous poor response <2 follicles (35%) Primary infertility with blocked tubes who could not afford conventional IVF (60%) Secondary infertility with blocked tubes who wanted to avoid multiple pregnancy (5%) Nargund et al Human Reprod 2001

Natural Cycle IVF Cumulative Conception & Live birth Rates: Nargund et al Human Reprod 2001-52 women &181 cycles (3.49 cycles/patient) -Life table analysis After 4 successive cycles of treatment Cumulative probability of pregnancy -46% Cumulative probability of Live birth -32%

Baseline ovarian ultrasound assessment Ovarian volume Stromal velocity AFC (<5mm & 5-9mm) R/O cyst/s

Treatment protocols-women>40 Natural /Modified natural cycle only AFC <3 /spontaneous ovulatory cycle Stromal PSV <5cm/sec Those with single oocyte/embryo with stimulated cycle Stimulated (Agonist flare) AFC>3 (3-8) Stromal PSV>5cm/sec (5-10cm/sec) Stimulated (Antagonist) AFC>8 & normal/high AMH Stromal PSV>10cm/sec

Women over 40 Natural & Stimulated cycles 2009-10 Protocol Age Group Total Pregnancy per cycle Pregnancy per ET Stimulated 40-42 121 11.6% 13.7% 43-44 36 8.3% 9.7% 45 3* Natural 40-42 100 9.0% 20.0% 43-44 57 7.0% 15.4% 45 14 0.0% 0.0% Total 331 *Low number of cycles

Clinical pregnancy rates based on FSH & AFC - NATURAL CYCLES (2009-10) Baseline FSH Total AFC Total Pregnancy per Cycle Pregnancy Per ET <10 <=6 44 6.8% 11.1% >=7 50 10.0% 26.3% 10-13 <=6 19 15.7% 30.0% >=7 9* 0.0%* 0.0%* >=14 <=6 45 6.6% 15.8% >=7 7 14.2% 20.0% Total 174 *Low number of cycles

Clinical pregnancy rates based on FSH AFC levels (2009-10) Stimulated cycles Baseline FSH Total AFC Total Pregnancy Rate per Cycle Pregnancy Rate per ET <10 <=6 44 18.2% 19.0% >=7 228 30.3% 33.8% 10-13 <=6 15 6.7% 10.0% >=7 14 21.4% 21.4% >=14 <=6 6* >=7 8* Total 315 *Low number of cycles

Clinical pregnancy rates based on FSH levels (2009-2010) This table includes pregnancy rates for completed cycles by women of all ages with various baseline FSH levels, having a stimulated or natural IVF/ICSI cycle. Protocol Baseline FSH Total Pregnancy rate per cycle Pregnancy rate per ET Stimulated <10 305 26.8% 29.8% 10-13 31 19.3% 23.1% >=14 15* Natural/ Modified natural <10 105 7.6% 16.6% 10-13 29 10.3% 21.4% >=14 53 7.5% 16.6% Total 538 *Low number of cycles

Natural cycle IVF: In Poor Responders Prospective study 22 poor responders over 1 year 44 NCIVF and 55 SIVF cycles 82% had one oocyte collected 41% had at least 1 cycle with ET 9% had a live birth Results of NCIVF & SIVF comparable Feldman et al: Gynae Endocrinology 2001

Semi-Natural IVF: In Poor prognosis patients Prospective study -133 cycles Altered ovarian status & Implantation failure 66 patients (AOS -47; IF-19) OPU rate (81.2%;61.1%) Clinical pregnancy rate/opu (15.4%;16.6%) Castelo-Branco A et al:gynae Obstet Biol Reprod: 2004

Controlled natural vs. micro dose GnRH flare cycles in poor responders 129 women with previous POR 59 women with 114 natural cycles 70 women with 101 flare protocol Similar pregnancy rates in both groups 14.9% implantation rate in natural cycles 5.5% implantation rate in flare cycles Morgia F et al Fertility & Sterility 2004

Modified Natural cycle IVF: In Poor Responders 540 cycles Retrospective evaluation MNIVF vs. Antagonist SIVF vs. LongSIVF 52 vs. 200 vs. 288 cycles 1.4 vs. 2.3 vs. 2.5 oocytes 10% vs. 14.3% vs. 6.75% implantation 10.2% vs. 7.4% vs. 10.6% pregnancies Elizur et al: Assist Reprod Genetics 2005

Natural cycle as first approach in older women undergoing ICSI: Pilot study 18 women Mean age -40.2± 0.7 years All had FSH & AMH 26 natural cycles with ICSI & single ET 11.5% clinical pregnancy/cycle 20% clinical pregnancy/et Papaleo E at al Gynaecol Endocrinol 2006

Embryo implantation rates in poor responders 304 women with previous POR Retrospective analysis Natural cycles -6/30 (20%) Gonadotrophin only-3/54 (5.6%) Long GnRH protocol 02/52 (3.8%) Co-flare protocol 1/52 (1.9%) Micro-flare 4/26 (15.4%) GnRH antagonists 13/90 (14.4%) There was a trend towards higher implantation rates with natural cycles Ata B,Yakin K,Balaban B,Urman B;RBM Online 2008

Natural cycles in poor responders 500 consecutive cycles Retrospective analysis 294 women with previous POR 391 oocytes collected (78.1%) 285 embryos suitable for transfer (57%) 49 pregnancies (9.8%/patient) Schimberni M et al;fertility & Sterility Oct 2009

Natural cycle IVF: In Poor Responders 294 patients & 500 consecutive cycles 35 : 36-39 : 40 years old 18.1% : 11.7% : 5.8% pregnancy/cycle 29.2% : 20.6% : 10.5% pregnancy/et 31.7% : 20.3% : 10.5% pregnancy/pt NCIVF is an effective treatment. Schimberni et al: Fertil Steril 2009

Conclusions Counselling regarding success rates with own/donor oocytes is essential in older women & those with POR Most women would like to try with their own oocytes before opting for donor oocytes Time frame for closure for treatment must be established Natural & modified natural cycle can be effective in older women and those with poor ovarian response & failure of implantation Further prospective,well designed studies are needed